Tinavi Medical Technologies Co Ltd (688277) — Capital Reinvestment Ratio
Tinavi Medical Technologies Co Ltd (688277) has a Capital Reinvestment Ratio of 0.04x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥24.50 Million) in capital expenditures (CN¥928.31K). See net asset quality index of Tinavi Medical Technologies Co Ltd to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Tinavi Medical Technologies Co Ltd Capital Reinvestment Ratio (2015–2019)
This chart tracks Tinavi Medical Technologies Co Ltd's Capital Reinvestment Ratio across 4 annual periods. Check how aggressively does Tinavi Medical Technologies Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Tinavi Medical Technologies Co Ltd (2015–2019)
Year-by-year Capital Reinvestment Ratio for Tinavi Medical Technologies Co Ltd from 2015 to 2019. For live market cap and broader valuation context, see Tinavi Medical Technologies Co Ltd market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.98x | CN¥20.53 Million | CN¥20.17 Million | ▼ -52.8% |
| 2018 | 2.08x | CN¥13.15 Million | CN¥27.36 Million | ▲ +89.9% |
| 2017 | 1.10x | CN¥5.73 Million | CN¥6.28 Million | ▲ +2709.1% |
| 2015 | 0.04x | CN¥41.82 Million | CN¥1.63 Million | — |